Expression of the Na +/K +-transporting ATPase gamma subunit FXYD2 in renal tumors

Modern Pathology

Volumn 26, Issue 5, 2013, Pages 716-724

  Gaut, Joseph P ^a   Crimmins, Dan L ^a   Lockwood, Christina M ^a   McQuillan, Jay J ^a   Ladenson, Jack H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

carcinoma; chromophobe; FXYD2; immunohistochemistry; oncocytoma; renal

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYTOKERATIN 7; FERRIC HYDROXIDE; FXYD2 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASOLATERAL MEMBRANE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 6; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; KIDNEY DISTAL TUBULE; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; SODIUM-POTASSIUM-EXCHANGING ATPASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84877023933     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2012.202     Document Type: Article

References (25)

1. Ljungberg B, Campbell SC, Choi HY, et al. The epidemiology of renal cell carcinoma. Eur Urol 2011;60:615-621.
2. Cho E, Adami HO, Lindblad P. Epidemiology of renal cell cancer. Hematol Oncol Clin North Am 2011;25:651-665.
3. Paner GP, Amin MB, Alvarado-Cabrero I, et al. A novel tumor grading scheme for chromophobe renal cell carcinoma. Prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol 2010;34:1233-1240.
4. Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 2010;183:1309-1315.
5. Capitanio U, Cloutier V, Zini L, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int 2009;103:1496-1500.
6. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol 1995;154:964-967.
7. Ficarra V, Brunelli M, Cheng L, et al. Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors. Eur Urol 2010;58:655-668.
8. Kuehn A, Paner GP, Skinnider BF, et al. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Am J Surg Pathol 2007;31:1528-1533.
9. Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med 2011;135: 92-109.
10. Speicher MR, Schoell B, Du Manoir S, et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 1994;145:356-364.
11. Kovacs A, Kovacs G. Low chromosome number in chromophobe renal cell carcinoma. Genes Chromosomes Cancer 1992;4:267-268.
12. Thoenes W, Störkel S, Rupelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas, carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986;181:125-143.
13. Leroy X, Moukassa D, Copin MC, et al. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 2000;37:484-487.
14. Thoenes W, Störkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1985;48:207-217.
15. Geering K. FXYD proteins: new regulators of Na-KATPase. Am J Physiol Renal Physiol 2006;290: F241-F250.
16. Arystarkhova E, Sweadner KJ. Splice variants of the gamma subunit (FXYD2) and their significance in regulation of the Na, K-ATPase in kidney. J Bioenerg Biomembr 2005;37:381-386.
17. Floyd RV, Wray S, Martin-Vasallo P, et al. Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays. Ann Anat 2010; 192:7-16.
18. Störkel S, Steart PV, Drenckhahn D, et al. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;56:237-245.
19. Osunkoya AO, Cohen C, Lawson D, et al. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum Pathol 2009;40:206-210.
20. Idol RA, Robledo S, Du HY, et al. Cells depleted for RPS19, a protein associated with Diamond Blackfan anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 2007;39:35-43.
21. Laterza OF, Modur VR, Crimmins DL, et al. Identification of novel brain biomarkers. Clin Chem 2006;52:1713-1721.
22. Delongchamps NB, Galmiche L, Eiss D, et al. Hybrid tumor 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a repot of seven sporadic cases. BJU Int 2009;103:1381-1384.
23. Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 2002;26:1542-1552.
24. Rohan S, Tu JJ, Kao J, et al. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res 2006;12:6937-6945.
25. Sweadner KJ, Pascoa JL, Salazar CA, et al. Posttranscriptional control of Na,K-ATPase activity and cell growth by a splice variant of FXYD2 protein with modified mRNA. J Biol Chem 2011;286:18290-18300.